Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine
- 1 November 1980
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 69 (11) , 1258-1261
- https://doi.org/10.1002/jps.2600691106
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Biological Fate of 4-Butyl-4-(β-carboxypropionyloxymethyl)-1, 2-diphenyl-3, 5-pyrazolidinedione (Suxibuzone), Antiinflammatory Drug. I. Plasma Levels and Urinary Excretion after Oral Administration of SuxibuzoneYAKUGAKU ZASSHI, 1979
- GLC Determination of Phenylbutazone in Human PlasmaJournal of Pharmaceutical Sciences, 1978
- Fully Automated Analysis of Phenylbutazone in Plasma and UrineJournal of Pharmaceutical Sciences, 1976
- Determination of phenylbutazone and its metabolites in plasma by gas-liquid chromatographic procedure.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- GLC Determination of Plasma Concentration of Phenylbutazone and its Metabolite OxyphenbutazoneJournal of Pharmaceutical Sciences, 1974
- Oxyphenbutazone and Phenylbutazone Determination in Plasma and Urine by GLCJournal of Pharmaceutical Sciences, 1974
- Analysis of phenylbutazone in plasma by high-speed liquid chromatographyJournal of Chromatography A, 1974
- The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedureJournal of Chromatography A, 1974
- Gas chromatographic assay of phenylbutazone in biological fluidsJournal of Chromatography A, 1971
- Ultraviolet Spectrophotometric Determination of Phenylbutazone in Biologic SpecimensJournal of Pharmaceutical Sciences, 1968